A similar trend was also observed in the colony formation; the combination of XRCC4 knockdown and cisplatin treatment strongly abolished the colony formation potential in the cisplatin-resistant ovarian cancer cell lines, supporting the role of XRCC4 in the regulation of cisplatin sensitivity (Figure 2f,g). Here, XRCC4 is linked to ovarian carcinoma.